Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth
-- Key additions deepen drug development expertise and position the Company to advance pipeline --VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds” or the “Company”), a biosciences company focused on creating the next generation of psychedelic and related therapies for the treatment of mental health and central nervous system disorders, today announced three additions to its scientific advisory team: John M. McCall, PhD, Senior Advisor; Mark A. Geyer, PhD, Advisor; and Uros Laban, Senior Chemist. “We are d...
Source: yahoo.com